NEW YORK, Oct. 31, 2019 /PRNewswire/ — In order to promote one’s business online, different platforms must be used. While some may be more applicable than others, they can be used to advertise to wider audiences. With this in mind, fishbat shares 3 types...
Geneva, Switzerland and Boston, MA – October 31, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s...
MORRISVILLE, N.C.–(BUSINESS WIRE)– 15 patients have been randomized 83% initial response rate to qualify for randomization Pulmonary capillary wedge pressure (PCWP) was reduced , on average, by 8 mmHg during exercise following the initial levosimendan...
Studies Aim to Confirm Safety and Efficacy of Novel Bio-inspired Clot-dissolving Therapy CAMBRIDGE, Mass, USA October 30, 2019 / B3C newswire / — Thrombolytic Science, LLC (TSI) today announced progress with 10 patients enrolled in its prospective, randomized,...
– Voclosporin ophthalmic solution (VOS) AUDREY trial results anticipated in the second half of 2020 – VICTORIA, British Columbia–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical...
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Oct. 31, 2019 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe unmet medical needs, today announced the publication of...
Email
Text